Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids
International Journal of Molecular Sciences · 22.12.2025 · 27 (1) · 123
DOI: 10.3390/ijms27010123 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.12.2025. Verfasst von Alice Ilari und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Surgery, Milano-Bicocca University, Via Cadore 48, 20900 Monza, Italy. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Neoplastic Stem Cells, Enhancer of Zeste Homolog 2 Protein, Spheroids, Cellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Triple Negative Breast Cancers (TNBCs) are heterogeneous and aggressive tumors with a median overall survival of less than two years. Despite the availability of new drugs, the prognosis remains poor, implicating a more aggressive clinical course in the metastatic setting. This study investigated the effects of metronomic treatment (mCHT) with 5-fluorouracil (5-FU) plus vinorelbine (VNR) on spheroids derived from two different TNBC cell lines (BT-549 and MDA-MB-231) and a patient-derived primary cell line (MS-186). mCHT significantly reduced spheroid growth and altered spheroid architecture, with a pronounced effect in second-generation spheroids, enriched in self-renewing cancer stem cells (CSCs). Expression of CSC-related markers (CD44, CD133, NOTCH-1, and MYC) was more significantly altered—both at the mRNA and protein levels—by mCHT than by standard treatment (STD). In MS-186-derived spheroids, mCHT downregulated EZH2 and STAT3, key regulators of CSC maintenance, and reduced H3K27ac, suggesting a global epigenetic reprogramming. Unlike STD, which partially and transiently reduced stemness markers, mCHT achieved sustained suppression, indicating preferential targeting of therapy-resistant CSCs. These results indicate mCHT as a promising strategy for specifically aiming at the CSC-like compartment in TNBC, underscoring a therapeutic approach that reprograms key epigenetic networks and overcomes resistance to treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Surgery, Milano-Bicocca University, Via Cadore 48, 20900 Monza, Italy.
- Department of Life Sciences, Health and Health Professions, Link Campus University, Via del Casale di San Pio V 44, 00165 Roma, Italy.
- Phase 1 Research Centre, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900 Monza, Italy.
ORCID-Profile: Emanuela Grassilli, Mario Mauri, Marina E Cazzaniga, Marialuisa Lavitrano, Maria Grazia Cerrito
Zitieren
APA
Ilari, A., Grassilli, E., Mauri, M., Cazzaniga, M. E., Capici, S., Lavitrano, M., & Cerrito, M. G. (2025). Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids. International Journal of Molecular Sciences, 27(1), 123. https://doi.org/10.3390/ijms27010123
Vancouver
Ilari A, Grassilli E, Mauri M, Cazzaniga ME, Capici S, Lavitrano M, et al. Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids. International Journal of Molecular Sciences. 2025;27(1):123. doi:10.3390/ijms27010123
BibTeX
@article{Ilari2025,
author = {Ilari, Alice and Grassilli, Emanuela and Mauri, Mario and Cazzaniga, Marina E and Capici, Serena and Lavitrano, Marialuisa and Cerrito, Maria Grazia},
title = {Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {27},
number = {1},
pages = {123},
doi = {10.3390/ijms27010123}
}
EUVIMED